Literature DB >> 30181346

Comparison of cardiac surgery mortality reports using administrative and clinical data sources: a prospective cohort study.

Cedric Manlhiot1, Vivek Rao1, Barry Rubin1, Douglas S Lee2.   

Abstract

BACKGROUND: Outcomes for coronary artery bypass surgery are of broadening interest, but the impact of data type on quality reporting has not been fully examined. We compared the performance of administrative and clinical data-based risk adjustment models at a tertiary-quaternary care hospital.
METHODS: We used a prospective study design to test two risk adjustment models, one from administrative (Canadian Institute for Health Information [CIHI] Cardiac Care Quality Indicator) and one from clinical data (Society of Thoracic Surgeons), on cardiac surgical procedures performed between 2013 and 2016 (n = 1635). Our primary outcome was in-hospital mortality within 30 days of surgery. Model performance was established by comparing predicted and observed mortality, model calibration and handling of critical covariates.
RESULTS: Observed mortality was 1.96%, which was the same as that predicted by the Society of Thoracic Surgeons model (1.96%), but significantly higher than that predicted by the CIHI model (1.03%). Despite both models having similar C statistics (0.756 CIHI; 0.758 Society of Thoracic Surgeons), the CIHI model showed significant underestimation of mortality among patients at higher risk. There was significant miscalibration of risk associated with 7 covariates: New York Heart Association class IV, congestive heart failure, ejection fraction less than 20%, atrial fibrillation, acute coronary insufficiency, cardiac compromise (shock, myocardial infarction < 24 h, intra-aortic balloon pump, cardiac resuscitation or preprocedure circulatory support) and creatinine concentration of 100 mg/dL or more. Together, these factors accounted for 84% of the difference in predicted mortality between the administrative and clinical models.
INTERPRETATION: Risk prediction using administrative data underestimated risk of death, potentially inflating observed-to-predicted mortality ratios at hospitals with patients who are more ill. Caution is warranted when hospital reports of cardiac surgery outcomes are based on administrative data alone. Copyright 2018, Joule Inc. or its licensors.

Entities:  

Year:  2018        PMID: 30181346      PMCID: PMC6182118          DOI: 10.9778/cmajo.20180072

Source DB:  PubMed          Journal:  CMAJ Open        ISSN: 2291-0026


  21 in total

1.  Estimating the number of coronary artery bypass graft and percutaneous coronary intervention procedures in Canada: a comparison of cardiac registry and Canadian Institute for Health Information data sources.

Authors:  Yana Gurevich; Anne McFarlane; Kathleen Morris; Aleksandra Jokovic; Gail M Peterson; Gregory K Webster
Journal:  Can J Cardiol       Date:  2010 Aug-Sep       Impact factor: 5.223

2.  Incremental value of clinical data beyond claims data in predicting 30-day outcomes after heart failure hospitalization.

Authors:  Bradley G Hammill; Lesley H Curtis; Gregg C Fonarow; Paul A Heidenreich; Clyde W Yancy; Eric D Peterson; Adrian F Hernandez
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-12-07

3.  Comparison of clinical and administrative data sources for hospital coronary artery bypass graft surgery report cards.

Authors:  David M Shahian; Treacy Silverstein; Ann F Lovett; Robert E Wolf; Sharon-Lise T Normand
Journal:  Circulation       Date:  2007-03-12       Impact factor: 29.690

4.  The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery.

Authors:  David M Shahian; Sean M O'Brien; Giovanni Filardo; Victor A Ferraris; Constance K Haan; Jeffrey B Rich; Sharon-Lise T Normand; Elizabeth R DeLong; Cynthia M Shewan; Rachel S Dokholyan; Eric D Peterson; Fred H Edwards; Richard P Anderson
Journal:  Ann Thorac Surg       Date:  2009-07       Impact factor: 4.330

5.  Using Both Clinical Registry and Administrative Claims Data to Measure Risk-adjusted Surgical Outcomes.

Authors:  Elise H Lawson; Rachel Louie; David S Zingmond; Greg D Sacks; Robert H Brook; Bruce Lee Hall; Clifford Y Ko
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

6.  Mortality after noncardiac surgery: prediction from administrative versus clinical data.

Authors:  Howard S Gordon; Michael L Johnson; Nelda P Wray; Nancy J Petersen; William G Henderson; Shukri F Khuri; Jane M Geraci
Journal:  Med Care       Date:  2005-02       Impact factor: 2.983

7.  Risk-Adjusted In-Hospital Mortality Models for Congestive Heart Failure and Acute Myocardial Infarction: Value of Clinical Laboratory Data and Race/Ethnicity.

Authors:  Eunjung Lim; Yongjun Cheng; Christine Reuschel; Omar Mbowe; Hyeong Jun Ahn; Deborah T Juarez; Jill Miyamura; Todd B Seto; John J Chen
Journal:  Health Serv Res       Date:  2015-06-15       Impact factor: 3.402

8.  Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial.

Authors:  Jack V Tu; Linda R Donovan; Douglas S Lee; Julie T Wang; Peter C Austin; David A Alter; Dennis T Ko
Journal:  JAMA       Date:  2009-11-18       Impact factor: 56.272

9.  Risk adjustment for coronary artery bypass graft surgery: an administrative approach versus EuroSCORE.

Authors:  Cristina Ugolini; Lucia Nobilio
Journal:  Int J Qual Health Care       Date:  2004-04       Impact factor: 2.038

10.  The Dutch hospital standardised mortality ratio (HSMR) method and cardiac surgery: benchmarking in a national cohort using hospital administration data versus a clinical database.

Authors:  S Siregar; M E Pouw; K G M Moons; M I M Versteegh; M L Bots; Y van der Graaf; C J Kalkman; L A van Herwerden; R H H Groenwold
Journal:  Heart       Date:  2013-12-13       Impact factor: 5.994

View more
  1 in total

1.  Non-home discharge after cardiac surgery in Australia and New Zealand: a cross-sectional study.

Authors:  Mahesh Ramanan; Aashish Kumar; Chris Anstey; Kiran Shekar
Journal:  BMJ Open       Date:  2021-12-23       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.